For instance, upregulation of insulin-like growth factor receptor (IGF1R), seen in subnetwork 3, has been identified in a wide variety of human cancers [18], and in vitro evidence suggests that this upregulation contributes to resistance against EGFR inhibitors [19]. This evidence concerns the gene EGFR and cancer.